Evidence map›Paper›PMID 10377177›Full record

ArticleThe Journal of clinical investigation1999

Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice.

S P Chapoval, G H Nabozny, E V Marietta, E L Raymond, C J Krco, A G Andrews, C S David

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

S P ChapovalDepartment of Immunology, Mayo Clinic, Rochester, Minnesota 55905, USA.
G H Nabozny
E V Marietta
E L Raymond
C J Krco
A G Andrews
C S David
Mayo Clinic · USBoehringer Ingelheim (Egypt) · EGUniversity of Veterinary Medicine · HU

Funding

GENETICS AND SEROLOGY OF H-2 (IR) LINKED IA ANTIGENSR01AI014764 · NIAID · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI DAVID, CHELLA S · 1985 to 2004
$1.7M
STRUCTURE EXPRESSION REGULATION OF MICE/HUMAN IA GENESR37AI014764 · NIAID · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI DAVID, CHELLA S · 1990 to 1999
–
NIAID NIH HHS AI-14764NIAID NIH HHS R01 AI014764NIAID NIH HHS R37 AI014764
6 · The paper itself

Abstract

The human leukocyte antigen (HLA) restriction of the IgE response to different allergens in humans has been a subject of numerous published studies. However, the role and contribution of specific HLA class II molecules in the pathogenesis of allergic airway inflammation are unknown and difficult to assess. HLA-DQ6 and HLA-DQ8 transgenic mice lacking endogenous mouse class II gene expression were actively immunized and later challenged intranasally with short ragweed (SRW) allergenic extract. The HLA-DQ transgenic mice developed pulmonary eosinophilia and lung tissue damage. We also found an increase in total protein (TP) level and IL-5 production in bronchoalveolar lavage (BAL) fluid and an increase in SRW-specific Th2-type immunoglobulins (IgG1, IgG2b) and total serum IgE levels. Under similar treatment, DQ-negative full-sib control mice were normal. The allergic response could be significantly inhibited or abrogated in HLA-DQ mice by systemic treatment with anti-DQ mAb. The in vivo responses of HLA-DQ6 and HLA-DQ8 mice showed differences in terms of levels of eosinophilia, BAL protein, IL-5 concentration, and lung hyperreactivity to inhaled methacholine. These findings demonstrate the crucial role for specific HLA-DQ molecules in SRW-specific CD4(+) T-cell activation and resulting recruitment of eosinophils into the airways.

Indexed as

RibonucleasesAdministration, IntranasalAllergensAnimalsAntibodies, MonoclonalAntigens, PlantBlood ProteinsBronchial HyperreactivityBronchoalveolar Lavage FluidCD4 AntigensEosinophil Granule ProteinsEpithelial CellsGene Expression RegulationHLA-DQ AntigensHumansImmune SeraAllergensAmb a III protein, Ambrosia artemisiifoliaAntibodies, MonoclonalAntigens, PlantBlood ProteinsCD4 AntigensEosinophil Granule ProteinsHLA-DQ AntigensImmune SeraImmunoglobulin EImmunosuppressive AgentsInterleukin-5Plant ProteinsRibonucleases

Identifiers

PMID10377177
PMCPMC408385
OpenAlexW2053826122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.